This inventor holds 1 USPTO granted patent. Top assignee: Mitotech Sa. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Evgeny S Efremov: Innovator in Pharmaceutical Science
Introduction
Evgeny S Efremov is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative substances that target mitochondrial functions. His work is characterized by a commitment to advancing medical treatments through scientific research and innovation.
Latest Patents
One of Efremov's notable patents is focused on pharmaceutical substances based on mitochondria-addressed antioxidants. The patent details purified pharmaceutical preparations comprising oxidized SkQ1, ensuring that no individual impurity exceeds 1.5%, with the total impurity content not exceeding 4.0%. Additionally, the content of reduced SkQ1 is limited to no more than 10%. This innovative approach highlights the potential for improved therapeutic options in the medical field.
Career Highlights
Evgeny S Efremov is associated with Mitotech SA, a company dedicated to developing advanced pharmaceutical solutions. His work at Mitotech has positioned him as a key figure in the research and development of mitochondrial-targeted therapies. Efremov's expertise and innovative mindset have contributed to the company's mission of enhancing health outcomes through cutting-edge science.
Collaborations
Throughout his career, Efremov has collaborated with notable scientists, including Maxim Vladimirovich Skulachev and Vladimir Petrovich Skulachev. These collaborations have fostered a rich exchange of ideas and have been instrumental in advancing research in the field of mitochondrial medicine.
Conclusion
Evgeny S Efremov stands out as a leading inventor in the realm of pharmaceutical innovations. His dedication to developing effective treatments through scientific research underscores the importance of innovation in healthcare. His contributions continue to pave the way for future advancements in the field.